The transit of dosage forms through the colon
- PMID: 20576492
- DOI: 10.1016/j.ijpharm.2010.04.044
The transit of dosage forms through the colon
Abstract
Colonic transit is a subject of great relevance when considering in vivo/in vitro relationships for oral controlled release dosage forms. Our knowledge of colonic motility has first come from the clinic, where measurement of the whole gut transit of different excreted markers was used as a method of discriminating pathologies. X-ray contrast, although widely available, was used sparing due to the accumulating dosimetry associated with each exposure. Although such methods were used for swallowing studies, gamma scintigraphy allowed physicians to measure colon function with a more moderate radiation burden. The ability to label meal and dosage form separately and to measure dispersion with more certainty, prompted the use in pharmaceutical sciences; finally, the relationship between blood concentrations and transit of different sized dosage began to be understood. This mini-review considers the development of colon transit measurements and how different designs of clinical assessment assist in elucidating size and shape influence on colon transit in man.
Copyright (c) 2010 Elsevier B.V. All rights reserved.
Similar articles
-
The transit of dosage forms through the small intestine.Int J Pharm. 2010 Aug 16;395(1-2):9-16. doi: 10.1016/j.ijpharm.2010.04.045. Epub 2010 May 15. Int J Pharm. 2010. PMID: 20478371 Review.
-
Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.Int J Pharm. 2010 Aug 16;395(1-2):26-36. doi: 10.1016/j.ijpharm.2010.04.046. Epub 2010 May 28. Int J Pharm. 2010. PMID: 20546855 Review.
-
Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.Pharm Dev Technol. 2009;14(1):116-25. doi: 10.1080/10837450802420559. Pharm Dev Technol. 2009. PMID: 18821272
-
Specific aspects of gastro-intestinal transit in children for drug delivery design.Int J Pharm. 2010 Aug 16;395(1-2):37-43. doi: 10.1016/j.ijpharm.2010.04.048. Epub 2010 May 15. Int J Pharm. 2010. PMID: 20478372
-
Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.J Nucl Med Technol. 2016 Mar;44(1):12-8. doi: 10.2967/jnumed.113.134551. J Nucl Med Technol. 2016. PMID: 26940448 Review.
Cited by
-
Application of In Vivo Imaging Techniques and Diagnostic Tools in Oral Drug Delivery Research.Pharmaceutics. 2022 Apr 6;14(4):801. doi: 10.3390/pharmaceutics14040801. Pharmaceutics. 2022. PMID: 35456635 Free PMC article. Review.
-
A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles.Drug Des Devel Ther. 2024 Feb 29;18:613-630. doi: 10.2147/DDDT.S439975. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38476206 Free PMC article. Review.
-
Nitinol Release of Nickel under Physiological Conditions: Effects of Surface Oxide, pH, Hydrogen Peroxide, and Sodium Hypochlorite.Shap Mem Superelasticity. 2022 Jun;8:98-106. doi: 10.1007/s40830-022-00364-3. Epub 2022 Apr 28. Shap Mem Superelasticity. 2022. PMID: 37720627 Free PMC article.
-
Predicting and Understanding the Human Microbiome's Impact on Pharmacology.Trends Pharmacol Sci. 2019 Jul;40(7):495-505. doi: 10.1016/j.tips.2019.04.014. Epub 2019 Jun 3. Trends Pharmacol Sci. 2019. PMID: 31171383 Free PMC article. Review.
-
Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota.Int J Mol Sci. 2016 Apr 6;17(4):509. doi: 10.3390/ijms17040509. Int J Mol Sci. 2016. PMID: 27058534 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources